Class Class II

Nova Max Creat eGFR Monitoring System (K251281)

K251281 2026-01-21 Traditional
Home/ Devices/ Nova Max Creat eGFR…

Description

Nova Max Creat eGFR Monitoring System by Nova Biomedical Corporation, an FDA 510(k) cleared clinical chemistry device.

Regulatory Information

Device ClassClass Class II
510(k) NumberK251281
Clearance Date2026-01-21
Clearance TypeTraditional
Product CodeSHB
Regulation Number862.1225

Categories

Need More Information?

Contact the manufacturer or request a quote for this device.

Request Quote
Scroll to Top